Attachment I - Page 1 
RECOMBINANT DNA ADVISORY CCMMITTEE 
WORKING Q*OUP ON TOXINS 
CHAIR 
GCHTESMAN, Dr. Susan K. 
Laboratory of Molecular Biology 
National Cancer Institute, 37/4B09 
National Institutes of Health 
Bethesda, Maryland 20205 
301 496-3 524 
BERNHEIMER, Dr. Alan W. 
Department of Microbiology 
New York University 
School of Medicine 
550 First Avenue 
New York, New York 10016 
212 340-5323 
COLLIER, Dr. John R. 
Department of Microbiology 
and Molecular Genetics 
Harvard Medical School 
Boston, Massachusetts 02115 
617 732-1930 
FORMAL,, Dr. Sam 
Department of Bacterial Disease 
Walter Reed Institute of Research 
Washington, DC 20307 
202 576-3344 
GITL, Dr. Michael 
Department of Microbiology 
Tufts University 
136 Harrison Avenue 
Roston, Massachusetts 02111 
617 956-6947 
HABIG, Dr. William 
Food and Drug Administration, 29/407 
8800 Rockville Pike 
Bethesda, Maryland 20205 
301 496-9695 
HOLMES, Dr. King K. 
Department of Medicine 
Harbor View Medical Center 
University of Washington 
Seattle, Washington 98104 
206 223-3361 
KDPECKD, Dr. Dennis J. 
Department of Bacterial Irrmmology 
Whiter Reed Institute of Research 
Washington, DC 20307 
202 576-3745 
LEVINE, Dr. Myron M. 
Center for Vaccine Development 
Division of Infectious Diseases 
University of Maryland 
Baltimore, Maryland 21201 
301 528-7588 
MAAS, Dr. Werner K. 
Department of Microbiology 
New York University 
School of Medicine 
New York, New York 10016 
212 340-5322 
EXECUTIVE SECRETARY 
MILEWSKJ, Dr. Elizabeth A. 
Office of Recombinant DNA Activities 
National Institute of Allergy 
ard Infectious Diseases, 31/3B10 
National Institutes of Health 
Bethesda, Maryland 20205 
301 496-6051 
[321] 
AUG 1985 
